Minocycline Hydrochloride Tablets
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Minocycline Hydrochloride Tablets contain the equivalent of NLT 90.0% and NMT 115.0% of the labeled amount of minocycline (C23H37N3O7).
2 IDENTIFICATION
A. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
PROCEDURE
Mobile phase: Dimethylformamide, tetrahydrofuran, 0.2 M ammonium oxalate, and 0.01 M edetate disodium (120:80:600:180). Adjust with ammonium hydroxide to a pH of 7.2.
System suitability solution: Dissolve 10 mg of USP Minocycline Hydrochloride RS in 20 mL of 0.2 M ammonium oxalate. Heat on a water bath at 60° for 3 h, allow to cool, and dilute with water to 25.0 mL..
Standard solution: 0.5 mg/mL of minocycline from USP Minocycline Hydrochloride RS in water. Use this solution within 3 h.
Sample solution: Nominally 0.5 mg/mL of minocycline from NLT 20 finely powdered Tablets in water. Shake for 1 min.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 280 nm
Column: 4.6-mm x 25-cm; 5-µm packing L1
Column temperature: 40°
Flow rate: 1.5 mL/min
Injection volume: 20 µL
System suitability
Samples: System suitability solution and Standard solution
[NOTE-The relative retention times for epiminocycline and minocycline are 0.7 and 1.0, respectively.]
Suitability requirements
Capacity factor: 5.0-11.5, Standard solution
Resolution: NLT 4.6 between epiminocycline and minocycline, System suitability solution
Tailing factor: 0.9-2.0 for minocycline, Standard solution
Relative standard deviation: NMT 2.0%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of minocycline (C23H37N3O7) in the portion of Tablets taken:
Result = (ru/rs ) × (Cs /Cu ) × P × F × 100
ru = peak response from the Sample solution
rs = peak response from the Standard solution
Cs = concentration of USP Minocycline Hydrochloride RS in the Standard solution (mg/mL)
Cu = nominal concentration of the Sample solution (mg/mL)
P = potency of minocycline in USP Minocycline Hydrochloride RS (µg/mg)
F = conversion factor, 0.001 mg/µg
Acceptance criteria: 90.0%–115.0%
4 PERFORMANCE TESTS
Dissolution 〈711〉
Medium: Water; 900 mL
Apparatus 2: 50 rpm
Time: 45 min
Detector: UV maximum at about 348 nm
Standard solution: USP Minocycline Hydrochloride RS in Medium
Sample solution: Sample per Dissolution 〈711〉. Dilute with Medium to a concentration that is similar to that of the Standard solution.
Tolerances: NLT 75% (Q) of the labeled amount of minocycline (C H N O ) is dissolved.
Uniformity of Dosage Units 〈905〉: Meet the requirements
5 SPECIFIC TESTS
Water Determination, Method I〈921〉: NMT 12.0%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, light-resistant containers.
USP Reference Standards 〈11〉

